Scientific Poster Presentations PM101 (NEXTERONE)

September 14, 2008, American College of Clinical Pharmacy, 37th Annual Meeting, Philadelphia, PA

Cushing DJ, Adams A, Cooper W, Kowey P, Lipicky R. PM101, a cyclodextrin-based IV of amiodarone, is bioequivalent to Amiodarone IV. DOWNLOAD PDF

Cushing DJ, Adams M, Cooper W, Kowey P, Lipicky R. PM101, a cyclodextrin-based IV formulation of amiodarone, is devoid of hypotensive effects. DOWNLOAD PDF

Cushing DJ, Lipicky R, Kowey P, Kudenchuk P, Cooper W, Gralinski M. Evaluation of the cardiac electrophysiologic effects of intravenous amiodarone formulations. DOWNLOAD PDF

November 18, 2008, American Association of Pharmaceutical Scientists Annual Meeting, Atlanta, GA

Cushing DJ, Lipicky R, Kowey P, Cooper W, Massey B, Gralinski M. PM101, a cyclodextrin-based intravenous formulation of amiodarone, is without hemodynamic effect in anesthetized dogs. DOWNLOAD PDF

December 9, 2008, American Society of Health Systems Pharmacists Midyear Clinical Meeting, Orlando, FL

Souney PF, Cowee J, Mosher G, Cushing DJ. Stability of intravenous amiodarone formulations in glass, polyolefin, and polyvinylchloride containers over 72 hours. DOWNLOAD PDF

For more information contact medicalaffairs@prismpharma.com